• Users Online: 137
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most popular articles (Since January 06, 2017)

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEWS
Pediatric high-grade glioma: A heterogeneous group of neoplasms with different molecular drivers
Francesca Gianno, Manila Antonelli, Elisabetta Ferretti, Maura Massimino, Antonietta Arcella, Felice Giangaspero
July-August 2018, 1(4):117-124
DOI:10.4103/glioma.glioma_27_18  
  8,552 1,101 5
Histological approach to neuronal and mixed neuronal-glial tumors of the central nervous system
Char Loo Tan, Roger E McLendon
May-June 2018, 1(3):89-96
DOI:10.4103/glioma.glioma_24_18  
  6,413 860 4
A multifaceted review of temozolomide resistance mechanisms in glioblastoma beyond O-6-methylguanine-DNA methyltransferase
Peter Y. M. Woo, Yi Li, Anna H. Y. Chan, Stephanie C. P. Ng, Herbert H. F. Loong, Danny T. M. Chan, George K. C. Wong, Wai-Sang Poon
April-June 2019, 2(2):68-82
DOI:10.4103/glioma.glioma_3_19  
  6,219 798 9
Gamma-delta T cells in glioblastoma immunotherapy
Sadhak Sengupta
January-March 2019, 2(1):30-36
DOI:10.4103/glioma.glioma_48_18  
  5,890 615 1
The advances in targeted therapy and immunotherapy for glioblastoma: Basic research and clinical trials
Mei Wang, Xiaochun Jiang, Fubing Wu, Haojun Xu, Zihong Lin, Bin Qi, Hongping Xia
May-June 2018, 1(3):79-88
DOI:10.4103/glioma.glioma_10_18  
  5,459 680 2
Combination of oncolytic viruses and immune checkpoint inhibitors in glioblastoma
Kunal Desai, Anne Hubben, Manmeet Ahluwalia
January-March 2019, 2(1):7-19
DOI:10.4103/glioma.glioma_5_19  
  5,225 441 1
Current concepts of imaging genomics in glioma
Ru-Jia Wang, Gui-Quan Shen, Mark S Shiroishi, Bo Gao
January-February 2018, 1(1):9-15
DOI:10.4103/glioma.glioma_1_18  
  4,649 708 1
Molecular mechanisms involved in angiogenesis and potential target of antiangiogenesis in human glioblastomas
Yang Xu, Fan-En Yuan, Qian-Xue Chen, Bao-Hui Liu
March-April 2018, 1(2):35-42
DOI:10.4103/glioma.glioma_10_17  
  4,705 623 7
Pediatric diffuse intrinsic pontine gliomas
Huber Said Padilla-Zambrano, Ezequiel Garcia-Ballestas, Amit Agrawal, Maximiliano Paez-Nova, Alfonso I Pacheco-Hernandez, Luis Rafael Moscote-Salazar
July-September 2019, 2(3):127-132
DOI:10.4103/glioma.glioma_50_18  
  4,809 258 -
How does one do next-generation sequencing for brain tumors in the clinical laboratories?
Kay Ka-Wai Li, Ho-Keung Ng
September-October 2018, 1(5):149-154
DOI:10.4103/glioma.glioma_36_18  
  4,452 494 1
ORIGINAL ARTICLES
BRAF mutation marks out specific subgroups of glioma
Aden Ka-Yin Chan, Riki Rui-Qi Zhang, Abudumijiti Aibaidula, Zhi Feng Shi, Hong Chen, Ying Mao, Ho Keung Ng
September-October 2018, 1(5):168-174
DOI:10.4103/glioma.glioma_33_18  
  4,019 487 5
REVIEWS
Immune checkpoint modulation: Tenets and implications in glioblastoma
John P Lynes, Victoria E Sanchez, Anthony K Nwankwo, Gifty A Dominah, Edjah K Nduom
January-March 2019, 2(1):20-29
DOI:10.4103/glioma.glioma_47_18  
  4,127 318 -
Ongoing evolution of response assessment in glioma: Where do we stand?
Li Yi, Haolang Ming, Shengping Yu, Bingcheng Ren, Xuejun Yang
May-June 2018, 1(3):97-103
DOI:10.4103/glioma.glioma_13_18  
  3,738 452 2
ORIGINAL ARTICLES
Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
Matthieu Dreyfus, Michèle El-Atifi, Magali Court, Marie Bidart, Charles Coutton, Céline Leclech, Bruno Ballester, Emmanuel Garcion, Ali Bouamrani, François Berger, Didier Wion
March-April 2018, 1(2):66-78
DOI:10.4103/glioma.glioma_3_18  
  3,661 393 1
REVIEWS
Current management of glioma in Pakistan
Umm E Hani Abdullah, Altaf Ali Laghari, Muhammad Usman Khalid, Huzaifa Bin Rashid, Adnan Abdul Jabbar, Fatima Mubarak, Asim Hafiz, Shahzad Shamim, Syed Ather Enam
July-September 2019, 2(3):139-144
DOI:10.4103/glioma.glioma_15_19  
  3,629 296 -
Advances in exosome-related biomarkers for glioblastoma: Basic research and clinical application
Yuzhen Jiang, Jiaying Qian, Jun Yang, Xiaoling Yan, Xiaoying Xue, Qing Chang
September-October 2018, 1(5):159-167
DOI:10.4103/glioma.glioma_35_18  
  3,279 486 1
Nanoparticles drug-delivery systems and antiangiogenic approaches in the treatment of gliomas
Maria Caffo, Salvatore Massimo Cardali, Elena Fazzari, Valeria Barresi, Gerardo Caruso
November-December 2018, 1(6):183-188
DOI:10.4103/glioma.glioma_43_18  
  3,363 398 4
ORIGINAL ARTICLES
Vasculogenic mimicry persists during glioblastoma xenograft growth
Cong Li, Yin-Sheng Chen, Qing-Ping Zhang, Jian-Liang Chen, Jing Wang, Fu-Rong Chen, Ho-Keung N G, Zhong-Ping Chen
January-February 2018, 1(1):16-21
DOI:10.4103/glioma.glioma_4_17  
  3,322 380 3
REVIEWS
Engineered T Cells for glioblastoma therapy
Junjie Zhong, Jianhong Zhu
July-August 2018, 1(4):125-131
DOI:10.4103/glioma.glioma_26_18  
  3,117 451 -
Angiogenesis in glioma
Fei-Yi-Fan Wang, Xue-Jun Li
March-April 2018, 1(2):43-49
DOI:10.4103/glioma.glioma_9_18  
  3,163 395 -
CASE REPORT
Diffuse midline glioma, H3-K27M mutant: Awareness leads to identification
Sadhana Tiwari, Ishita Pant, Sujata Chaturvedi, Gurbachan Singh
January-March 2019, 2(1):55-59
DOI:10.4103/glioma.glioma_1_19  
  3,283 253 1
REVIEWS
Myeloid-derived suppressor cells and nonresolving inflammatory cells in glioma microenvironment: molecular mechanisms and therapeutic strategies
Xiao-Yan Ji, Jia-Wei Ma, Jun Dong
January-February 2018, 1(1):2-8
DOI:10.4103/glioma.glioma_2_17  
  3,128 386 3
ORIGINAL ARTICLES
Clinical and magnetic resonance imaging features of spinal cord glioblastoma multiforme in a series of 12 cases: A single-institutional experience
Fuyou Guo, Guoqing Wang, Vigneyshwar Suresh, Dingkang Xu, Xiaoyang Zhang, Mengzhao Feng, Fang Wang, Xianzhi Liu, Laijun Song
May-June 2018, 1(3):111-116
DOI:10.4103/glioma.glioma_25_18  
  3,152 357 1
REVIEWS
Importance of iatrogenic immunosuppression in the treatment of patients with high-grade glioma with immunotherapy
Anna F Piotrowski, Stuart A Grossman
January-March 2019, 2(1):3-6
DOI:10.4103/glioma.glioma_8_19  
  3,210 261 -
Role of natural killer cells in isocitrate dehydrogenase 1/2 mutant glioma pathogenesis and emerging therapies
Xiaoran Zhang, Aleksandra Safonova, Aparna Rao, Nduka Amankulor
July-September 2019, 2(3):133-138
DOI:10.4103/glioma.glioma_10_19  
  3,111 327 2